Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2014, Article ID 932595, 4 pages
http://dx.doi.org/10.1155/2014/932595
Case Report

Potential Additive Effects of Ticagrelor, Ivabradine, and Carvedilol on Sinus Node

1Division of Cardiology, Ospedale San Pietro Fatebenefratelli, 00189 Rome, Italy
2Division of Cardiology, P.O. Di Venere, Via Ospedale di Venere, No. 1, 70131 Bari, Italy

Received 22 July 2014; Accepted 9 September 2014; Published 29 September 2014

Academic Editor: Antonio de Padua Mansur

Copyright © 2014 Luigi Di Serafino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Diaz, M. G. Bourassa, M.-C. Guertin, and J.-C. Tardif, “Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease,” European Heart Journal, vol. 26, no. 10, pp. 967–974, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. D. DiFrancesco and P. Tortora, “Direct activation of cardiac pacemaker channels by intracellular cyclic AMP,” Nature, vol. 351, no. 6322, pp. 145–147, 1991. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Fox, I. Ford, P. G. Steg, M. Tendera, and R. Ferrari, “Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial,” The Lancet, vol. 372, no. 9641, pp. 807–816, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Dominguez-Rodriguez, S. S. Fard, P. Abreu-Gonzalez et al., “Randomised, double-blind, placebo-controlled trial of ivabradine in patients with acute coronary syndrome: effects of the I(f) current inhibitor ivabradine on reduction of inflammation markers in patients with acute coronary syndrome—riviera trial study design and rationale,” Cardiovascular Drugs and Therapy, vol. 23, no. 3, pp. 243–247, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Wallentin, R. C. Becker, A. Budaj et al., “Ticagrelor versus clopidogrel in patients with acute coronary syndromes,” The New England Journal of Medicine, vol. 361, no. 11, pp. 1045–1057, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. C. P. Cannon, S. Husted, R. A. Harrington et al., “Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-st-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial,” Journal of the American College of Cardiology, vol. 50, no. 19, pp. 1844–1851, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. G. A. West and L. Belardinelli, “Correlation of sinus slowing and hyperpolarization caused by adenosine in sinus node,” Pflugers Archiv European Journal of Physiology, vol. 403, no. 1, pp. 75–81, 1985. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Belardinelli, J. C. Shryock, Y. Song, D. Wang, and M. Srinivas, “Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes,” The FASEB Journal, vol. 9, no. 5, pp. 359–365, 1995. View at Google Scholar · View at Scopus
  9. L. Belardinelli, W. R. Giles, and A. West, “Ionic mechanisms of adenosine actions in pacemaker cells from rabbit heart,” The Journal of Physiology, vol. 405, pp. 615–633, 1988. View at Google Scholar · View at Scopus
  10. R. A. Olsson and J. D. Pearson, “Cardiovascular purinoceptors,” Physiological Reviews, vol. 70, no. 3, pp. 761–845, 1990. View at Google Scholar · View at Scopus